Annals of Diagnostic Pathology
Volume 14, Issue 1 , Pages 50-55 , February 2010

Desmoplastic fibroma with malignant transformation

  • Hye Sook Min, MD, PhD

      Affiliations

    • Department of Pathology, National Cancer Center, Goyang, Gyoung-Gi, Korea
    • ,
  • Hyun Gyui Kang, MD, PhD

      Affiliations

    • Orthopedic Surgery, National Cancer Center, Goyang, Gyoung-Gi, Korea
    • ,
  • Joo-Hyuk Lee, MD, PhD

      Affiliations

    • Diagnostic Radiology, National Cancer Center, Goyang, Gyoung-Gi, Korea
    • Department of Pathology, Weill Medical College of Cornell University, The Methodist Hospital, Houston, TX 77030, USA
    • ,
  • Geon Kook Lee, MD, PhD

      Affiliations

    • Department of Pathology, National Cancer Center, Goyang, Gyoung-Gi, Korea
    • ,
  • Jae Y. Ro, MD, PhD

      Affiliations

    • Diagnostic Radiology, National Cancer Center, Goyang, Gyoung-Gi, Korea
    • Department of Pathology, Weill Medical College of Cornell University, The Methodist Hospital, Houston, TX 77030, USA
    • Corresponding Author InformationCorresponding author. Department of Pathology, Weill Medical College of Cornell University, The Methodist Hospital, Houston, TX 77030, USA.

References 

  1. Dorfman H, Czerniak B. Bone tumors. Philadelphia: Mosby; 1998;
  2. Fletcher C, Unni KK, Mertens F. Pathology and genetics of tumours of soft tissue and bone. Lyon: IARC; 2002;
  3. Abdelwahab IF, Klein MJ, Hermann G, et al. Osteosarcoma arising in a desmoplastic fibroma of the proximal tibia. AJR Am J Roentgenol. 2002;178(3):613–615
  4. Takazawa K, Tsuchiya H, Yamamoto N, et al. Osteosarcoma arising from desmoplastic fibroma treated 16 years earlier: a case report. J Orthop Sci. 2003;8(6):864–868
  5. Randelli G. Desmoid fibromas of bone. Arch Ortop. 1964;77(6):523–527
  6. Bohm P, Krober S, Greschniok A, et al. Desmoplastic fibroma of the bone. A report of two patients, review of the literature, and therapeutic implications. Cancer. 1996;78(5):1011–1023
  7. Cho YL, Bae S, Koo MS, et al. Array comparative genomic hybridization analysis of uterine leiomyosarcoma. Gynecol Oncol. 2005;99(3):545–551
  8. Van Blarcom CW, Masson JK, Dahlin DC. Fibrosarcoma of the mandible. A clinicopathologic study. Oral Surg Oral Med Oral Pathol. 1971;32(3):428–439
  9. Inwards CY, Unni KK, Beabout JW, et al. Desmoplastic fibroma of bone. Cancer. 1991;68(9):1978–1983
  10. Evans HL. Liposarcoma: a study of 55 cases with a reassessment of its classification. Am J Surg Pathol. 1979;3(6):507–523
  11. Meis JM. “Dedifferentiation” in bone and soft-tissue tumors. A histological indicator of tumor progression. Pathol Annu. 1991;26(Pt 1):37–62
  12. Morimitsu Y, Aoki T, Yokoyama K, et al. Sarcomatoid chordoma: chordoma with a massive malignant spindle-cell component. Skeletal Radiol. 2000;29(12):721–725
  13. McCormick D, Mentzel T, Beham A, et al. Dedifferentiated liposarcoma. Clinicopathologic analysis of 32 cases suggesting a better prognostic subgroup among pleomorphic sarcomas. Am J Surg Pathol. 1994;18(12):1213–1223
  14. Weiss SW, Rao VK. Well-differentiated liposarcoma (atypical lipoma) of deep soft tissue of the extremities, retroperitoneum, and miscellaneous sites. A follow-up study of 92 cases with analysis of the incidence of “dedifferentiation. Am J Surg Pathol. 1992;16(11):1051–1058
  15. Bridge JA, Swarts SJ, Buresh C, et al. Trisomies 8 and 20 characterize a subgroup of benign fibrous lesions arising in both soft tissue and bone. Am J Pathol. 1999;154(3):729–733
  16. Bridge JA, Rosenthal H, Sanger WG, et al. Desmoplastic fibroma arising in fibrous dysplasia. Chromosomal analysis and review of the literature. Clin Orthop Relat Res. 1989;(247):272–278
  17. Berner JM, Meza-Zepeda LA, Kools PF, et al. HMGIC, the gene for an architectural transcription factor, is amplified and rearranged in a subset of human sarcomas. Oncogene. 1997;14(24):2935–2941
  18. Reid AH, Tsai MM, Venzon DJ, et al. MDM2 amplification, P53 mutation, and accumulation of the P53 gene product in malignant fibrous histiocytoma. Diagn Mol Pathol. 1996;5(1):65–73
  19. Sakabe T, Shinomiya T, Mori T, et al. Identification of a novel gene, MASL1, within an amplicon at 8p23.1 detected in malignant fibrous histiocytomas by comparative genomic hybridization. Cancer Res. 1999;59(3):511–515
  20. Simons A, Schepens M, Jeuken J, et al. Frequent loss of 9p21 (p16(INK4A)) and other genomic imbalances in human malignant fibrous histiocytoma. Cancer Genet Cytogenet. 2000;118(2):89–98
  21. Larramendy ML, Gentile M, Soloneski S, et al. Does comparative genomic hybridization reveal distinct differences in DNA copy number sequence patterns between leiomyosarcoma and malignant fibrous histiocytoma. Cancer Genet Cytogenet. 2008;187(1):1–11
  22. Tarkkanen M, Larramendy ML, Bohling T, et al. Malignant fibrous histiocytoma of bone: analysis of genomic imbalances by comparative genomic hybridisation and C-MYC expression by immunohistochemistry. Eur J Cancer. 2006;42(8):1172–1180
  23. Chibon F, Mariani O, Mairal A, et al. The use of clustering software for the classification of comparative genomic hybridization data. an analysis of 109 malignant fibrous histiocytomas. Cancer Genet Cytogenet. 2003;141(1):75–78
  24. Hattinger CM, Tarkkanen M, Benini S, et al. Genetic analysis of fibrosarcoma of bone, a rare tumour entity closely related to osteosarcoma and malignant fibrous histiocytoma of bone. Eur J Cell Biol. 2004;83(9):483–491
  25. Idbaih A, Coindre JM, Derre J, et al. Myxoid malignant fibrous histiocytoma and pleomorphic liposarcoma share very similar genomic imbalances. Lab Invest. 2005;85(2):176–181
  26. Nishio J, Iwasaki H, Ishiguro M, et al. Establishment of a new human malignant fibrous histiocytoma cell line, FU-MFH-1: cytogenetic characterization by comparative genomic hybridization and fluorescence in situ hybridization. Cancer Genet Cytogenet. 2003;144(1):44–51
  27. Ohguri T, Hisaoka M, Kawauchi S, et al. Cytogenetic analysis of myxoid liposarcoma and myxofibrosarcoma by array-based comparative genomic hybridisation. J Clin Pathol. 2006;59(9):978–983
  28. Weng WH, Wejde J, Ahlen J, et al. Characterization of large chromosome markers in a malignant fibrous histiocytoma by spectral karyotyping, comparative genomic hybridization (CGH), and array CGH. Cancer Genet Cytogenet. 2004;150(1):27–32
  29. Tarkkanen M, Kaipainen A, Karaharju E, et al. Cytogenetic study of 249 consecutive patients examined for a bone tumor. Cancer Genet Cytogenet. 1993;68(1):1–21
  30. Stock C, Kager L, Fink FM, et al. Chromosomal regions involved in the pathogenesis of osteosarcomas. Genes Chromosomes Cancer. 2000;28(3):329–336
  31. Ozaki T, Schaefer KL, Wai D, et al. Genetic imbalances revealed by comparative genomic hybridization in osteosarcomas. Int J Cancer. 2002;102(4):355–365
  32. dos Santos Aguiar S, de Jesus Girotto Zambaldi L, dos Santos AM, et al. Comparative genomic hybridization analysis of abnormalities in chromosome 21 in childhood osteosarcoma. Cancer Genet Cytogenet. 2007;175(1):35–40
  33. Hallor KH, Heidenblad M, Brosjo O, et al. Tiling resolution array comparative genomic hybridization analysis of a fibrosarcoma of bone. Cancer Genet Cytogenet. 2007;172(1):80–83
  34. Bahk WJ, Kang YK, Lee AH, et al. Desmoid tumor of bone with enchondromatous nodules, mistaken for chondrosarcoma. Skeletal Radiol. 2003;32(4):223–226
  35. Callahan KS, Eberhardt SC, Fechner RE, et al. Desmoplastic fibroma of bone with extensive cartilaginous metaplasia. Ann Diagn Pathol. 2006;10(6):343–346
  36. Dahlin DC, Bertoni F, Beabout JW, et al. Fibrocartilaginous mesenchymoma with low-grade malignancy. Skeletal Radiol. 1984;12(4):263–269
  37. Bulychova IV, Unni KK, Bertoni F, et al. Fibrocartilagenous mesenchymoma of bone. Am J Surg Pathol. 1993;17(8):830–836

PII: S1092-9134(09)00039-2

doi: 10.1016/j.anndiagpath.2009.04.004

Annals of Diagnostic Pathology
Volume 14, Issue 1 , Pages 50-55 , February 2010

Article Tools

* Image Usage & Resolution